{
  "content": ". Amiodarone’s noncompetitive β-blockade can lead to bradycardia, which may be wors-ened by hypothyroidism. QT/QTc interval prolongation occurs with both amiodarone and hypothyroidism, but the risk of severe arrhythmias is relatively low . Due to its high efficacy, amiodarone is frequently the sole antiarrhythmic option available to patients, and it is commonly administered alongside levothyroxine (L-T4) replacement. L-T4 is preferred, especially for individuals with cardiac issues, due to its once-daily dosing and lack of serum thyroid hormone concentration spikes seen with lio-J. Clin. Med. 2024 , 13 , 6094 14 of 27",
  "source": "https://pdfs.semanticscholar.org/eda9/09ebe34c58658072d9d3a1e6db13d581c6cd.pdf?skipShowableCheck=true",
  "chunk_id": "c8cba38e-0b41-4e08-a975-fa25a1860427",
  "similarity_score": 0.40661048889160156,
  "query": "amiodarone adverse effects side effects safety profile atrial fibrillation thyroid pulmonary hepatic toxicity",
  "rank": 48,
  "title": "Amiodarone Therapy: Updated Practical Insights",
  "authors": "Sorodoc, V., Indrei, L., Dobroghii, C., Asaftei, A., Ceasovschih, A., Constantin, M., Lionte, C., Morărașu, B. C., Diaconu, A.-D., Sorodoc, L.",
  "year": "2024",
  "journal": "Journal of Clinical Medicine",
  "reference": "Sorodoc, V., Indrei, L., Dobroghii, C., Asaftei, A., Ceasovschih, A., Constantin, M., Lionte, C., Morărașu, B. C., Diaconu, A.-D., & Sorodoc, L. (2024). Amiodarone therapy: Updated practical insights. Journal of Clinical Medicine, 13(20), 6094. https://doi.org/10.3390/jcm13206094",
  "doi": "10.3390/jcm13206094",
  "chunk_index": 100,
  "total_chunks": 209,
  "retrieved_at": "2025-07-24T21:57:51.201665"
}